GIOVANNETTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 1.939
AS - Asia 934
EU - Europa 834
SA - Sud America 162
AF - Africa 56
OC - Oceania 12
Totale 3.937
Nazione #
US - Stati Uniti d'America 1.869
SG - Singapore 305
IT - Italia 278
CN - Cina 265
BR - Brasile 134
HK - Hong Kong 133
GB - Regno Unito 97
SE - Svezia 89
DE - Germania 69
VN - Vietnam 54
AT - Austria 50
BG - Bulgaria 48
CA - Canada 45
NL - Olanda 45
IN - India 38
FI - Finlandia 36
FR - Francia 32
TR - Turchia 30
RU - Federazione Russa 29
JP - Giappone 27
SN - Senegal 20
KR - Corea 17
AU - Australia 12
UA - Ucraina 12
PL - Polonia 11
ZA - Sudafrica 11
BD - Bangladesh 9
BE - Belgio 9
IQ - Iraq 8
TW - Taiwan 8
AR - Argentina 7
MX - Messico 7
EG - Egitto 6
ES - Italia 6
PK - Pakistan 6
CI - Costa d'Avorio 5
IR - Iran 5
LU - Lussemburgo 5
EC - Ecuador 4
JM - Giamaica 4
MA - Marocco 4
NP - Nepal 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
JO - Giordania 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CU - Cuba 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KY - Cayman, isole 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MK - Macedonia 2
NG - Nigeria 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BM - Bermuda 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IE - Irlanda 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TC - Turks e Caicos 1
TZ - Tanzania 1
Totale 3.937
Città #
Ashburn 221
Woodbridge 177
Singapore 168
Fairfield 140
Dallas 137
Hong Kong 131
Chandler 124
Santa Clara 118
Ann Arbor 115
Houston 114
Serra 71
Shanghai 67
Seattle 54
London 51
New York 50
Beijing 49
Wilmington 49
Sofia 48
Vienna 47
Cambridge 46
Los Angeles 41
Boardman 39
Pisa 33
Munich 27
Princeton 25
Dakar 20
Lawrence 19
Amsterdam 18
Izmir 18
Redwood City 18
Medford 16
São Paulo 16
Ho Chi Minh City 15
Ottawa 15
Redondo Beach 15
Tokyo 14
Dearborn 13
Turku 13
Florence 12
Hefei 12
Washington 12
Nanjing 11
Des Moines 10
Frankfurt am Main 9
Helsinki 9
Lucca 9
Hyderabad 8
Manchester 8
Rome 8
Toronto 8
Brussels 7
Buffalo 7
Dong Ket 7
Istanbul 7
Nuremberg 7
Pittsburgh 7
Taipei 7
Utrecht 7
Belo Horizonte 6
Guangzhou 6
Hamilton 6
Hanoi 6
Johannesburg 6
Livorno 6
Marseille 6
Montreal 6
Mumbai 6
Ogden 6
Pistoia 6
Poplar 6
San Diego 6
Seoul 6
Talence 6
Abidjan 5
Bologna 5
Denver 5
Grafing 5
Mexico City 5
Orem 5
Wuhan 5
Chicago 4
Council Bluffs 4
Kunming 4
Lund 4
Madrid 4
Piombino 4
Quanzhou 4
Seodaemun-gu 4
Shenyang 4
Stockholm 4
Atlanta 3
Baghdad 3
Baku 3
Boulder 3
Campinas 3
Chennai 3
Columbus 3
Da Nang 3
Delhi 3
Düsseldorf 3
Totale 2.719
Nome #
GLUT1 and LOX inhibitors as perspective anticancer agents tackling glucose avidity and ECM remodeling in tumors 246
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 217
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 213
Blood platelet RNA yields a new diagnostic prospective for accurate detection and staging of pancreatic ductal adenocarcinoma 184
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer 182
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 181
Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. 159
The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter 156
A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1 155
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation. 154
Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer. 154
The biology of regulatory pathways of miRNAs, mRNAs and proteins unravels a specific -omics network in tumor-educated platelets from pancreatic cancer patients 148
MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside. 147
Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2 147
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies 144
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. 142
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds 131
Genetic variation: effect on prostate cancer 128
Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing 118
Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study 106
null 104
The Current Role of Single-Site Robotic Approach in Liver Resection: A Systematic Review 75
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC) 75
The effect of lactate dehydrogenase-A inhibition on intracellular nucleotides and mitochondrial respiration in pancreatic cancer cells 75
Delayed gastric emptying after pylorus‐preserving pancreatoduodenectomy: Comparison between traditional open surgery and full‐robotic approach with da Vinci Xi 71
Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study 66
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target 65
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma 59
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma 57
Thinking small to win big? A critical review on the potential application of extracellular vesicles for biomarker discovery and new therapeutic approaches in pancreatic cancer 47
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers 45
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism 41
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right direction 20
Totale 4.012
Categoria #
all - tutte 11.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 0 54 18 36 12 16 34
2021/2022300 13 6 11 19 36 42 25 41 10 9 18 70
2022/2023461 34 98 40 27 66 51 6 35 65 4 19 16
2023/2024273 12 16 43 6 30 65 12 7 3 13 28 38
2024/2025991 7 35 23 54 77 110 79 34 71 116 126 259
2025/2026791 106 179 151 116 142 97 0 0 0 0 0 0
Totale 4.012